Lyon Joseph Douglas sold Corcept Therapeutics Inc. ($CORT) shares on the open market 19 times over the last year, totaling $23.5 million, with his most recent sale on December 1, 2025. His sales rank 596th among nearly 12,000 insiders, exceeding the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 398 | $0.00 | 11,319.0000 | 119,981,000 | 3.64% | 0.00% |
| March 2, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 398 | $35.97 | 10,921.0000 | 119,981,000 | 3.78% | 0.00% |
| March 3, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | F | Common Stock | 89 | $35.97 | 11,230.0000 | 119,981,000 | 0.79% | 0.00% |
| Feb. 27, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 119,981,000 | 9999.99% | 0.12% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 178 | $79.78 | 10,455.0000 | 119,981,000 | 1.73% | 0.00% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5000 | $13.56 | 15,277.0000 | 119,981,000 | 48.65% | 0.00% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 5000 | $79.53 | 10,277.0000 | 119,981,000 | 32.73% | 0.00% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5000 | $0.00 | 11,571.0000 | 119,981,000 | 30.17% | 0.00% |
| Dec. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | F | Common Stock | 110 | $79.78 | 10,523.0000 | 119,981,000 | 1.03% | 0.00% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 178 | $0.00 | 10,633.0000 | 119,981,000 | 1.70% | 0.00% |
| Nov. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 5000 | $73.65 | 10,277.0000 | 119,981,000 | 32.73% | 0.00% |
| Nov. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5000 | $0.00 | 16,571.0000 | 119,981,000 | 23.18% | 0.00% |
| Nov. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5000 | $13.56 | 15,277.0000 | 119,981,000 | 48.65% | 0.00% |
| Oct. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 927 | $83.71 | 14,350.0000 | 119,981,000 | 6.07% | 0.00% |
| Oct. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5000 | $13.56 | 15,277.0000 | 119,981,000 | 48.65% | 0.00% |
| Oct. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 3473 | $84.92 | 10,877.0000 | 119,981,000 | 24.20% | 0.00% |
| Oct. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 600 | $85.39 | 10,277.0000 | 119,981,000 | 5.52% | 0.00% |
| Oct. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5000 | $0.00 | 21,571.0000 | 119,981,000 | 18.82% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 4895 | $70.24 | 10,171.0000 | 113,480,000 | 32.49% | 0.00% |
| Sept. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | F | Common Stock | 189 | $71.38 | 10,277.0000 | 113,480,000 | 1.81% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 200 | $0.00 | 10,466.0000 | 113,480,000 | 1.95% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5000 | $0.00 | 26,571.0000 | 113,480,000 | 15.84% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5000 | $13.56 | 15,066.0000 | 113,480,000 | 49.67% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 200 | $71.38 | 10,266.0000 | 113,480,000 | 1.99% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 105 | $70.76 | 10,066.0000 | 113,480,000 | 1.03% | 0.00% |
| Aug. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 5823 | $67.51 | 10,066.0000 | 113,480,000 | 36.65% | 0.01% |
| Aug. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5823 | $0.00 | 31,571.0000 | 113,480,000 | 15.57% | 0.01% |
| Aug. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5823 | $13.56 | 15,889.0000 | 113,480,000 | 57.85% | 0.01% |
| July 18, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 200 | $0.00 | 37,394.0000 | 113,480,000 | 0.53% | 0.00% |
| July 17, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 3877 | $13.56 | 13,943.0000 | 113,480,000 | 38.52% | 0.00% |
| July 17, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 3877 | $0.00 | 37,594.0000 | 113,480,000 | 9.35% | 0.00% |
| July 18, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 200 | $73.40 | 10,066.0000 | 113,480,000 | 1.95% | 0.00% |
| July 18, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 200 | $13.56 | 10,266.0000 | 113,480,000 | 1.99% | 0.00% |
| July 17, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 3877 | $73.48 | 10,066.0000 | 113,480,000 | 27.81% | 0.00% |
| July 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 100 | $73.51 | 10,066.0000 | 113,480,000 | 0.98% | 0.00% |
| July 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 100 | $13.56 | 10,166.0000 | 113,480,000 | 0.99% | 0.00% |
| July 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 100 | $0.00 | 41,471.0000 | 113,480,000 | 0.24% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5000 | $0.00 | 41,571.0000 | 113,480,000 | 10.74% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5000 | $13.56 | 14,009.0000 | 113,480,000 | 55.50% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 4438 | $77.97 | 9,751.0000 | 113,480,000 | 31.28% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 562 | $78.65 | 9,009.0000 | 113,480,000 | 5.87% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 749 | $71.68 | 9,758.0000 | 113,480,000 | 8.31% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 749 | $0.00 | 10,507.0000 | 113,480,000 | 7.68% | 0.00% |
| June 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | F | Common Stock | 441 | $71.68 | 10,066.0000 | 113,480,000 | 4.20% | 0.00% |
| May 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 9350 | $71.96 | 9,009.0000 | 113,480,000 | 50.93% | 0.01% |
| May 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 9350 | $13.56 | 18,359.0000 | 113,480,000 | 103.79% | 0.01% |
| May 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 9350 | $0.00 | 46,571.0000 | 113,480,000 | 16.72% | 0.01% |
| April 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 650 | $13.56 | 9,659.0000 | 113,480,000 | 7.22% | 0.00% |
| April 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 650 | $0.00 | 55,921.0000 | 113,480,000 | 1.15% | 0.00% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 50000 | $0.00 | 50,000.0000 | 113,480,000 | 50.00% | 0.04% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 40000 | $0.00 | 0.0000 | 113,480,000 | 100.00% | 0.04% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 75000 | $0.00 | 0.0000 | 113,480,000 | 100.00% | 0.07% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 35000 | $0.00 | 56,571.0000 | 113,480,000 | 38.22% | 0.03% |
| April 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 650 | $114.53 | 9,009.0000 | 113,480,000 | 6.73% | 0.00% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 5050 | $102.48 | 9,009.0000 | 113,480,000 | 35.92% | 0.00% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 32942 | $101.37 | 14,059.0000 | 113,480,000 | 70.09% | 0.03% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 162008 | $100.22 | 47,001.0000 | 113,480,000 | 77.51% | 0.14% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 50000 | $19.26 | 209,009.0000 | 113,480,000 | 31.44% | 0.04% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 40000 | $15.82 | 159,009.0000 | 113,480,000 | 33.61% | 0.04% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 75000 | $16.52 | 119,009.0000 | 113,480,000 | 170.42% | 0.07% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 35000 | $13.56 | 44,009.0000 | 113,480,000 | 388.50% | 0.03% |
| March 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 421 | $0.00 | 91,571.0000 | 113,480,000 | 0.46% | 0.00% |
| March 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 421 | $60.58 | 9,009.0000 | 113,480,000 | 4.46% | 0.00% |
| March 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 421 | $13.56 | 9,430.0000 | 113,480,000 | 4.67% | 0.00% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 4579 | $60.69 | 9,009.0000 | 113,480,000 | 33.70% | 0.00% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 4579 | $13.56 | 13,588.0000 | 113,480,000 | 50.83% | 0.00% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 216 | $0.00 | 9,009.0000 | 113,480,000 | 2.46% | 0.00% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | F | Common Stock | 182 | $60.58 | 8,577.0000 | 113,480,000 | 2.08% | 0.00% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 4579 | $0.00 | 91,992.0000 | 113,480,000 | 4.74% | 0.00% |
| Feb. 28, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Stock option (right to buy) | 140000 | $0.00 | 140,000.0000 | 113,480,000 | 9999.99% | 0.12% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 216 | $59.07 | 8,793.0000 | 113,480,000 | 2.52% | 0.00% |
| Feb. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 1571 | $0.00 | 2,596.0000 | 113,480,000 | 37.70% | 0.00% |
| Feb. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 3429 | $0.00 | 96,571.0000 | 113,480,000 | 3.43% | 0.00% |
| Feb. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 1571 | $11.35 | 10,330.0000 | 113,480,000 | 17.94% | 0.00% |
| Feb. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 3429 | $13.56 | 13,759.0000 | 113,480,000 | 33.19% | 0.00% |
| Feb. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 5000 | $66.92 | 8,759.0000 | 113,480,000 | 36.34% | 0.00% |
| Jan. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5000 | $0.00 | 4,167.0000 | 113,480,000 | 54.54% | 0.00% |
| Jan. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5000 | $11.35 | 13,759.0000 | 113,480,000 | 57.08% | 0.00% |
| Jan. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 5000 | $50.39 | 8,759.0000 | 113,480,000 | 36.34% | 0.00% |
| Dec. 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 215 | $59.21 | 8,544.0000 | 113,723,000 | 2.58% | 0.00% |
| Dec. 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 215 | $0.00 | 8,759.0000 | 113,723,000 | 2.52% | 0.00% |
| Dec. 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | F | Common Stock | 165 | $57.68 | 8,329.0000 | 113,723,000 | 1.94% | 0.00% |
| Nov. 22, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 1411 | $56.72 | 8,494.0000 | 113,723,000 | 14.25% | 0.00% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | F | Common Stock | 129 | $35.30 | 9,161.0000 | 111,742,000 | 1.39% | 0.00% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 372 | $34.26 | 9,533.0000 | 111,742,000 | 4.06% | 0.00% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 372 | $0.00 | 9,905.0000 | 111,742,000 | 3.90% | 0.00% |
| July 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 5000 | $32.49 | 9,290.0000 | 111,742,000 | 34.99% | 0.00% |
| July 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5000 | $11.35 | 14,290.0000 | 111,742,000 | 53.82% | 0.00% |
| July 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5000 | $0.00 | 9,167.0000 | 111,742,000 | 35.29% | 0.00% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 5000 | $30.18 | 7,314.0000 | 111,742,000 | 40.60% | 0.00% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | F | Common Stock | 488 | $30.17 | 6,826.0000 | 111,742,000 | 6.67% | 0.00% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 1232 | $31.30 | 8,058.0000 | 111,742,000 | 18.05% | 0.00% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | A | Common Stock | 1232 | $0.00 | 9,290.0000 | 111,742,000 | 15.29% | 0.00% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5000 | $0.00 | 14,167.0000 | 111,742,000 | 26.09% | 0.00% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5000 | $11.35 | 12,314.0000 | 111,742,000 | 68.36% | 0.00% |
| May 9, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 7227 | $11.35 | 14,541.0000 | 111,742,000 | 98.81% | 0.01% |
| May 9, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 7227 | $0.00 | 19,167.0000 | 111,742,000 | 27.38% | 0.01% |
| May 9, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 7227 | $26.00 | 7,314.0000 | 111,742,000 | 49.70% | 0.01% |
| May 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 10830 | $0.00 | 26,394.0000 | 111,742,000 | 29.09% | 0.01% |
| May 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 10830 | $26.00 | 7,314.0000 | 111,742,000 | 59.69% | 0.01% |
| May 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 10830 | $11.35 | 18,144.0000 | 111,742,000 | 148.07% | 0.01% |
| April 4, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 5443 | $11.35 | 12,757.0000 | 111,742,000 | 74.42% | 0.00% |
| April 4, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 5443 | $0.00 | 37,224.0000 | 111,742,000 | 12.76% | 0.00% |
| April 4, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 5443 | $26.00 | 7,314.0000 | 111,742,000 | 42.67% | 0.00% |
| April 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | S | Common Stock | 500 | $26.01 | 7,314.0000 | 111,742,000 | 6.40% | 0.00% |
| April 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Stock option (right to buy) | 500 | $0.00 | 42,667.0000 | 111,742,000 | 1.16% | 0.00% |
| April 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | See Remarks | M | Common Stock | 500 | $11.35 | 7,814.0000 | 111,742,000 | 6.84% | 0.00% |
| March 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 507 | $24.06 | 6,807.0000 | 111,742,000 | 8.05% | 0.00% |
| March 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | F | Common Stock | 474 | $24.06 | 6,300.0000 | 111,742,000 | 7.00% | 0.00% |
| March 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 507 | $0.00 | 7,314.0000 | 111,742,000 | 7.45% | 0.00% |
| Feb. 16, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock option (right to buy) | 1000 | $0.00 | 43,167.0000 | 111,742,000 | 2.26% | 0.00% |
| Feb. 16, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 1000 | $11.35 | 7,774.0000 | 111,742,000 | 14.76% | 0.00% |
| Feb. 16, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 1000 | $26.00 | 6,774.0000 | 111,742,000 | 12.86% | 0.00% |
| Feb. 9, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Stock option (right to buy) | 150000 | $0.00 | 150,000.0000 | 111,742,000 | 9999.99% | 0.13% |
| Dec. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock option (right to buy) | 5000 | $0.00 | 44,167.0000 | 115,966,000 | 10.17% | 0.00% |
| Dec. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 2568 | $11.35 | 8,422.0000 | 115,966,000 | 43.87% | 0.00% |
| Dec. 4, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 2432 | $26.00 | 5,854.0000 | 115,966,000 | 29.35% | 0.00% |
| Dec. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 460 | $25.97 | 6,314.0000 | 115,966,000 | 7.86% | 0.00% |
| Dec. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 2568 | $26.00 | 5,854.0000 | 115,966,000 | 30.49% | 0.00% |
| Dec. 4, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 2432 | $11.35 | 8,286.0000 | 115,966,000 | 41.54% | 0.00% |
| Dec. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 460 | $0.00 | 6,774.0000 | 115,966,000 | 7.29% | 0.00% |
| Nov. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 1023 | $28.08 | 5,854.0000 | 115,966,000 | 14.88% | 0.00% |
| Nov. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 1023 | $11.35 | 6,877.0000 | 115,966,000 | 17.48% | 0.00% |
| Nov. 2, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 3977 | $11.35 | 9,831.0000 | 115,966,000 | 67.94% | 0.00% |
| Nov. 2, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 3977 | $28.11 | 5,854.0000 | 115,966,000 | 40.45% | 0.00% |
| Nov. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock option (right to buy) | 1023 | $0.00 | 53,144.0000 | 115,966,000 | 1.89% | 0.00% |
| Nov. 2, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock option (right to buy) | 3977 | $0.00 | 49,167.0000 | 115,966,000 | 7.48% | 0.00% |
| Oct. 6, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 2582 | $11.35 | 8,436.0000 | 115,966,000 | 44.11% | 0.00% |
| Oct. 6, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 2582 | $27.24 | 5,854.0000 | 115,966,000 | 30.61% | 0.00% |
| Oct. 6, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock option (right to buy) | 2582 | $0.00 | 54,167.0000 | 115,966,000 | 4.55% | 0.00% |
| Oct. 2, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock option (right to buy) | 2418 | $0.00 | 2,418.0000 | 115,966,000 | 50.00% | 0.00% |
| Oct. 2, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 2418 | $11.35 | 8,272.0000 | 115,966,000 | 41.31% | 0.00% |
| Oct. 2, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 2418 | $27.25 | 5,854.0000 | 115,966,000 | 29.23% | 0.00% |
| Sept. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 59,167.0000 | 115,966,000 | 7.79% | 0.00% |
| Sept. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 361 | $0.00 | 5,854.0000 | 115,966,000 | 6.57% | 0.00% |
| Sept. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 361 | $33.10 | 5,493.0000 | 115,966,000 | 7.03% | 0.00% |
| Sept. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 5000 | $32.73 | 5,132.0000 | 115,966,000 | 49.35% | 0.00% |
| Sept. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 5000 | $11.35 | 10,132.0000 | 115,966,000 | 97.43% | 0.00% |
| Aug. 21, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 833 | $11.35 | 9,720.0000 | 115,966,000 | 9.37% | 0.00% |
| Aug. 21, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 3755 | $8.27 | 8,887.0000 | 115,966,000 | 73.17% | 0.00% |
| Aug. 21, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock option (right to buy) | 3755 | $0.00 | 0.0000 | 115,966,000 | 100.00% | 0.00% |
| Aug. 21, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 4588 | $31.19 | 5,132.0000 | 115,966,000 | 47.20% | 0.00% |
| Aug. 21, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock option (right to buy) | 833 | $0.00 | 64,167.0000 | 115,966,000 | 1.28% | 0.00% |
| Aug. 7, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock Option (Right to Buy) | 412 | $0.00 | 51,571.0000 | 115,966,000 | 0.79% | 0.00% |
| Aug. 7, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 412 | $8.27 | 5,132.0000 | 115,966,000 | 8.73% | 0.00% |
| Aug. 7, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 412 | $31.22 | 4,720.0000 | 115,966,000 | 8.03% | 0.00% |
| June 6, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | S | Common Stock | 10000 | $23.60 | 5,132.0000 | 115,966,000 | 66.09% | 0.01% |
| June 6, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Common Stock | 10000 | $11.35 | 15,132.0000 | 115,966,000 | 194.86% | 0.01% |
| June 6, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | M | Stock option (right to buy) | 10000 | $0.00 | 56,571.0000 | 115,966,000 | 15.02% | 0.01% |
| June 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 1411 | $0.00 | 5,132.0000 | 115,966,000 | 37.92% | 0.00% |
| June 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 1411 | $22.97 | 3,721.0000 | 115,966,000 | 61.08% | 0.00% |
| March 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 1155 | $19.86 | 1,155.0000 | 115,966,000 | 9999.99% | 0.00% |
| March 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Common Stock | 1155 | $0.00 | 2,310.0000 | 115,966,000 | 100.00% | 0.00% |
| Feb. 13, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Lyon Joseph Douglas | Chief Accounting Officer | A | Stock option (right to buy) | 120000 | $0.00 | 120,000.0000 | 115,966,000 | 9999.99% | 0.10% |